Our Pricing

Expert Tips for Mounjaro Dosage Chart Success

Published on: June 03, 2026

Understanding the mounjaro dosage chart uk guide is essential for achieving optimal weight loss results while minimising side effects. At Cured Pharmacy, our UK-registered clinical team helps patients navigate the tirzepatide dose escalation schedule safely, with Mounjaro available from £124.99 following a free online consultation with a UK prescriber.

Understanding the Mounjaro Dosage Chart UK Schedule

Mounjaro (tirzepatide) follows a structured dose escalation protocol designed to improve gastrointestinal tolerance whilst maximising weight loss efficacy [1]. The UK-licensed dosing schedule begins at 2.5 mg once weekly for four weeks, serving as an initiation dose rather than a therapeutic dose.

After the initial month, your prescriber will typically increase your dose to 5 mg weekly, with further escalations to 7.5 mg, 10 mg, 12.5 mg, and finally 15 mg at four-week intervals, subject to individual tolerance and clinical response [1]. This gradual titration approach significantly reduces the risk of nausea, vomiting, and diarrhoea compared to starting at higher doses.

In the SURPASS-1 trial, patients following this escalation protocol experienced substantially fewer gastrointestinal discontinuations compared to rapid dose increases, whilst still achieving an average 15-22.5% body weight reduction depending on final maintenance dose [1][2].

Why Gradual Dose Escalation Matters

The four-week intervals between dose increases allow your gastrointestinal system to adapt to tirzepatide's effects on gastric emptying and appetite regulation. Rushing this process increases the likelihood of intolerable side effects that may lead to treatment discontinuation, undermining your weight loss goals [2].

How to Administer Your Mounjaro Injection Correctly

Proper injection technique is crucial for ensuring consistent medication absorption and minimising injection site reactions. Mounjaro KwikPens are designed for subcutaneous injection into the abdomen, thigh, or upper arm, rotating sites weekly to prevent lipohypertrophy [3].

Before injecting, allow the pen to reach room temperature for 30 minutes to reduce injection discomfort. Clean the injection site with an alcohol wipe, pinch the skin gently, and insert the needle at a 90-degree angle. Press and hold the injection button until you hear a second click, then count to five slowly before withdrawing the needle to ensure full dose delivery [3].

Inject Mounjaro on the same day each week, choosing a consistent time that fits your routine. If you miss a dose and it's been less than four days, administer it as soon as possible. If more than four days have passed, skip the missed dose and resume your regular schedule — never double dose to compensate [3].

Managing Side Effects During Dose Escalation

Gastrointestinal side effects are most common during the first few weeks after each dose increase, typically resolving within 7-14 days as your body adjusts [2]. Nausea affects approximately 20-30% of patients but can be managed effectively with dietary modifications and timing strategies.

To minimise nausea, eat smaller, more frequent meals rather than three large meals daily. Avoid high-fat, spicy, or heavily processed foods, which delay gastric emptying further. Stay well-hydrated throughout the day, sipping water regularly rather than drinking large volumes at once [4].

If side effects become intolerable at a particular dose, contact your prescriber before your next scheduled increase. They may recommend maintaining your current dose for an additional four weeks rather than escalating, or prescribing anti-nausea medication such as domperidone or prochlorperazine to bridge the adjustment period [4].

When to Contact Your Prescriber

Seek immediate medical attention if you experience severe abdominal pain that doesn't resolve, persistent vomiting preventing fluid intake, signs of pancreatitis (severe upper abdominal pain radiating to the back), or symptoms of thyroid tumours (lump in the neck, difficulty swallowing, persistent hoarseness). These are rare but serious adverse effects requiring prompt evaluation [4].

Optimising Weight Loss Results on Mounjaro

Whilst tirzepatide produces significant weight loss through appetite suppression and improved glycaemic control, combining medication with lifestyle modifications enhances outcomes considerably. Clinical trial data shows patients who engaged in structured diet and exercise programmes alongside Mounjaro achieved 3-5% additional weight loss compared to medication alone [1][2].

Focus on protein-rich foods at each meal to preserve lean muscle mass during weight loss. Aim for 1.2-1.6 grams of protein per kilogram of ideal body weight daily, distributed across meals. This macronutrient strategy helps maintain metabolic rate and prevents the muscle loss that typically accompanies rapid weight reduction [5].

Incorporate resistance training twice weekly to further protect muscle tissue. Even modest strength training — bodyweight exercises, resistance bands, or light weights — signals your body to prioritise fat loss over muscle catabolism, improving body composition outcomes beyond what the scale reflects [5].

Mounjaro Dosage Chart UK: What Dose Is Right for You?

Your optimal maintenance dose depends on individual factors including weight loss response, side effect tolerance, and clinical goals discussed with your UK prescriber. Some patients achieve their target weight loss at 5-7.5 mg weekly, whilst others require escalation to 12.5-15 mg for maximal efficacy [1].

In the SURPASS-3 trial, the 15 mg dose produced the greatest average weight reduction at 22.5% over 72 weeks, compared to 19.5% at 10 mg and 15% at 5 mg [1]. However, higher doses also correlate with increased gastrointestinal side effects, requiring careful risk-benefit assessment.

Your prescriber will evaluate weight loss velocity, metabolic improvements (blood pressure, HbA1c if diabetic, lipid profile), and quality of life considerations when determining whether to continue dose escalation or maintain your current level. The goal is finding the lowest effective dose that achieves clinically meaningful weight loss — defined as ≥5% body weight reduction — whilst remaining tolerable long-term [2].

Personalising Your Mounjaro Treatment Plan

At Cured Pharmacy, your UK prescriber reviews your progress regularly through follow-up consultations, adjusting your dosage schedule based on real-world response rather than rigid protocols. This personalised approach optimises outcomes whilst prioritising safety and treatment adherence throughout your weight loss journey.

Comparing Mounjaro to Other Weight Loss Treatments

Mounjaro represents the latest advancement in obesity pharmacotherapy, offering superior weight loss outcomes compared to earlier GLP-1 receptor agonists through its dual GIP/GLP-1 mechanism [1][2]. Understanding how tirzepatide compares to alternatives helps you make informed treatment decisions with your prescriber.

Wegovy (semaglutide) activates only GLP-1 receptors, producing an average 15% weight loss over 68 weeks in the STEP-1 trial — substantial but lower than Mounjaro's 22.5% at comparable timeframes [2]. Saxenda (liraglutide) requires daily injections and achieves approximately 8% weight loss, making it less convenient and less effective than weekly options [6].

Oral medications like Orlistat work through fat malabsorption rather than appetite regulation, producing modest 3-5% weight loss but with gastrointestinal side effects including oily stools and faecal urgency [6]. Injectable treatments like Mounjaro offer superior efficacy for patients requiring substantial weight reduction, though they require prescription approval and cost considerations.

Choosing Between Injectable Weight Loss Treatments

Your UK prescriber will consider your BMI, weight loss goals, previous treatment responses, injection preference (daily versus weekly), budget, and comorbidities when recommending between Mounjaro, Wegovy, or Saxenda. All three require clinical assessment and ongoing monitoring, available through Cured Pharmacy's streamlined online consultation process.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
4. Dahl, D., Onishi, Y., Norwood, P., et al. (2022). Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA, 327(6), 534–545. https://doi.org/10.1001/jama.2022.0078 [accessed 13 August 2026]
5. Pasiakos, S. M., Cao, J. J., Margolis, L. M., et al. (2013). Effects of high-protein diets on fat-free mass and muscle protein synthesis following weight loss: a randomized controlled trial. FASEB Journal, 27(9), 3837–3847. https://doi.org/10.1096/fj.13-230227 [accessed 13 August 2026]
6. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments including Mounjaro require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence, lifestyle modifications, and individual metabolic response.